Profile for European Patent Office Patent: 2371361
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Denmark | CA 2019 00044 | ⤷ Start Trial |
| Germany | 122019000082 | ⤷ Start Trial |
| Belgium | 2019C/544 | ⤷ Start Trial |
| Lithuania | PA2019018 | ⤷ Start Trial |
| Luxembourg | LUC00139 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2371361
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
